Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
← Research & Industry News
External source

Autolomous and Cellular Origins link cell-therapy workflows

The collaboration combines Constellation and autoloMATE to address fragmented manufacturing data and process visibility. The announcement concerns a product, collaboration or production plan; it does not by itself establish clinical benefit or verified scale-up performance.

Published by
GEN — Genetic Engineering & Biotechnology News
Evidence type
Industry

GEN reports: The collaboration combines Constellation and autoloMATE to address fragmented manufacturing data and process visibility.

The announcement concerns a product, collaboration or production plan; it does not by itself establish clinical benefit or verified scale-up performance. Consult the linked GEN report for the source organisation’s full announcement.

Autolomous and Cellular Origins link cell-therapy workflows | Brilliant Blue Biosciences